Goldfarb Branham Law Firm Pursuing Potential Shareholder Claims Against Clarient Due to Buyout
22 Ottobre 2010 - 5:15PM
Business Wire
Goldfarb Branham LLP is investigating whether the Clarient, Inc.
(NASDAQ:CLRT) Board of Directors breached fiduciary duties to
shareholders in connection with the proposed acquisition of the
company by GE Healthcare. If you are a Clarient shareholder you are
encouraged to contact securities lawyer Hamilton Lindley at
877-583-2855 or hlindley@goldfarbbranham.com.
“Clarient will be acquired by GE Healthcare for $5.00 per share
in cash,” said securities lawyer Hamilton Lindley. “However, at
least one analyst has set a price target of $6.00 per share for
Clarient stock. Our proposed class action lawsuit seeks to maximize
the money and information that shareholders can receive under this
transaction.”
Goldfarb Branham LLP has significant experience representing
investors, at no cost to them, in securities lawsuits nationwide.
Firm lawyers have been lead counsel on major securities lawsuits,
including some of the largest transactions in the world and
shareholder litigation stemming from the BP oil spill. Contact
Hamilton Lindley at 877-583-2855 or
hlindley@goldfarbbranham.com.
Grafico Azioni Clarient, Inc. (MM) (NASDAQ:CLRT)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Clarient, Inc. (MM) (NASDAQ:CLRT)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Clarient, Inc. (MM) (NASDAQ): 0 articoli recenti
Più Goldfarb Branham LLP Articoli Notizie